查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
體脂減少的全球市場:市場規模 - 各手術，各服務供應商，性別，各地區展望，競爭策略，各市場區隔預測(～2030年)
市場調查報告書
商品編碼
1159595

體脂減少的全球市場:市場規模 - 各手術，各服務供應商，性別，各地區展望，競爭策略，各市場區隔預測(～2030年)

Body Fat Reduction Market Size - By Procedure, By Service Provider, By Gender- Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 256 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球體脂減少的市場規模，預計至2030年達到161億2,000萬美元，以8.2％的年複合成長率成長。

由於不良的飲食習慣，對由於生活方式的變化，運動不足，久坐的生活方式帶來的肥胖案例增加，及肥胖的政府政策和計劃，手術的採用，促進體脂減少市場。由於更廉價，侵入性、不適感低，結果的風險也低，微侵襲性治療法，預計獨佔市場。

本報告提供全球體脂減少市場相關調查，市場動態，市場變數及預測，各手術、服務供應商、性別、地區的市場分析，企業簡介等相關資訊。

目錄

第1章 簡介

  • 調查範圍
  • 市場區隔分析

第2章 調查手法

  • 調查資料來源
  • 市場規模的估計
  • 資料的三角測量

第3章 摘要整理

第4章 市場動態

  • 促進因素，阻礙因素，機會，課題的分析
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 全球體脂減少市場上COVID-19的影響

第5章 市場變數及預測

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • PESTEL分析
    • 政治形勢
    • 經濟形勢
    • 社會形勢
    • 技術形勢
    • 環境形勢
    • 法律上的形勢
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係
  • 熱圖分析

第6章 全球體脂減少市場:各手術，2019年～2030年(100萬美元)

  • 外科
    • 腹部形成術
    • 抽脂
  • 非外科
    • 超音波
    • 凍結脂解法
    • 其他

第7章 全球體脂減少市場:各服務供應商，2019年～2030年(100萬美元)

  • 醫院
  • 診所
  • 醫療SPA
  • 其他

第8章 全球體脂減少市場:各性別，2019年～2030年(100萬美元)

  • 女性
  • 男性

第9章 全球體脂減少市場:各地區，2019年～2030年(100萬美元)

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他的亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中東、非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 其他的中東、非洲

第10章 企業簡介

  • AbbVie Inc. (Allergan Inc.)
    • 企業概要
    • 財務預測
    • 產品概要
    • 最近的開發
  • Apollo Hospitals Enterprise Limited
  • Bausch Health Companies Inc.
  • Cutera, Inc.
  • Candela Medical
  • Cynosure, Llc
  • Lumenis Ltd
  • Sciton Inc.
  • Sisram Medical Ltd
  • VLCC Health Care Limited
簡介目錄
Product Code: HLCA2215

Global Body Fat Reduction Market Overview:

According to SPER Market Research, the Global Body Fat Reduction Market is estimated to reach USD 16.12 billion by 2030 with a CAGR of 8.2%.

Body fat reduction is the term used to describe a reduction in total body weight brought on by the loss of fluid, adipose tissue, or lean mass, including bone mineral deposits, muscle, tendon, and other connective tissue. It is the process of reducing extra body fat with a variety of goals in mind, such as improving the shape and appearance of the body. Adipose tissue, or body fat, has particular roles in the metabolism and endocrine system. The removal of extra adipose tissue or fats from the body via surgical or non-surgical means is a common practice in cosmetic surgery. there are many treatments on the market, including abdominoplasty (tummy tuck), laser lipolysis, cryolipolysis, liposuction, ultrasound, red light therapy, and injectable therapy.

Obesity is a growing public health issue in both industrialised and emerging nations, largely due to the population's unhealthy, stressful lifestyle. In addition to genetic, physiological, and environmental factors, eating habits, exercise preferences, and physical activity levels all contribute to obesity. People use surgical and non-surgical methods to achieve their goal of losing body fat. thus, it is anticipated that the body fat reduction market will grow due to the rise in obesity cases brought on by bad eating habits, lifestyle changes, lack of exercise, and adoption of a sedentary lifestyle, as well as favourable government policies and programmes for obesity that are encouraging the adoption of body fat reduction procedures.

Due to its emphasis on minimum blood loss, shorter patient stays, safety, and convenience of use, minimally invasive therapy approaches for body fat removal are becoming more and more popular. Because they are more affordable, less intrusive, and uncomfortable, and have a lower risk of consequences, minimally invasive procedures are predicted to dominate the market. The procedure of enhancing the appearance of the face and body is known as aesthetic plastic surgery (sometimes referred to as cosmetic surgery). Increased demand for surgical and non-surgical body contouring or body shaping procedures also contributes to the market's expansion.

In addition, surgeries to lose weight or alter the body after childbirth are becoming more popular. Young people and women are becoming more conscious of their physical appearance and fitness levels in order to achieve body slimming. Therefore, it is anticipated that these factors will significantly drive the expansion of the body fat reduction market over the forecast period.

The global fat reduction market is segmented n the basis of procedure, service provider and gender. On the basis of procedure, the surgical segment dominated the market is expected to dominate the market during forecast period due to rising demand for weight loss and obesity treatments and aesthetic improvement operations. On the basis of service provider, hospitals and clinics subsegment is expected to dominate during the forecast period. On the basis of gender, the female subsegment will dominate the market due to elf-conscious about having attractive and artistic appearances. However, the high cost of these procedures and some side effects following therapy are anticipated to hinder market expansion.

Impact of COVID-19 on the Global Body Fat Reduction Market

The COVID-19 pandemic has had a significant negative influence on the expansion of the body fat reduction sector since it has temporarily halted some medical treatments and suspended some aesthetic treatment procedures. However, a rise in weight gain difficulties was caused by the temporary closure of fitness centres and the adoption of the work from home (WFH) culture, which is predicted to spur market expansion over the course of the projection period.

Scope of the report

Report Metric Details

Market size available for years 2019-2030

Base year considered 2021

Forecast period 2022-2030

Segments covered By Procedure, By Service Provider, By Gender

Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Covered AbbVie Inc. (Allergan Inc.), Apollo Hospitals Enterprise Limited, Bausch Health Companies Inc., Cutera, Inc., Candela Medical, Cynosure, Llc, Lumenis Ltd, Sciton Inc., Sisram Medical Ltd, Vlcc Health Care Limited.

Global Body Fat Reduction Market Segmentation:

By Procedure: Based on the Procedure, Global Body Fat Reduction Market is segmented as; Surgical (Abdominoplasty, Liposuction), Non-Surgical (Ultrasound, Cryolipolysis, Others).

By Service Provider: Based on the Service Provider, Global Body Fat Reduction Market is segmented as; Hospitals, Clinics, Medical Spas, Others.

By Gender: Based on the Gender, Global Body Fat Reduction Market is segmented as; Females and Males.

By Region: North America is expected to maintain its leadership position during the projection period. Due to the rising frequency of obesity cases, the existence of important players, an increase in healthcare spending, technological improvements, and an increase in regional government efforts.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Body Fat Reduction Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Body Fat Reduction Market, By Procedure, 2019-2030 (USD Million)

  • 6.1 Surgical
    • 6.1.1 Abdominoplasty
    • 6.1.2 Liposuction
  • 6.2 Non-Surgical
    • 6.2.1 Ultrasound
    • 6.2.2 Cryolipolysis
    • 6.2.3 Others

7. Global Body Fat Reduction Market, By Service Provider, 2019-2030 (USD Million)

  • 7.1 Hospitals
  • 7.2 Clinics
  • 7.3 Medical Spas
  • 7.4 Others

8. Global Body Fat Reduction Market, By Gender, 2019-2030 (USD Million)

  • 8.1 Females
  • 8.2 Males

9 Global Body Fat Reduction Market, By Region, 2019-2030 (USD Million)

  • 9.1 North America
    • 9.1.1. United States
    • 9.1.2. Canada
    • 9.1.3. Mexico
  • 9.2 Europe
    • 9.2.1. Germany
    • 9.2.2. United Kingdom
    • 9.2.3. France
    • 9.2.4. Italy
    • 9.2.5. Spain
    • 9.2.6. Rest of Europe
  • 9.3 Asia-Pacific
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. India
    • 9.3.4. Australia
    • 9.3.5. South Korea
    • 9.3.6. Rest of Asia-Pacific
  • 9.4 South America
    • 9.4.1. Brazil
    • 9.4.2. Argentina
    • 9.4.3. Rest of South America
  • 9.5 Middle East & Africa
    • 9.5.1. Kingdom of Saudi Arabia
    • 9.5.2. United Arab Emirates
    • 9.5.3. Rest of Middle East & Africa

10 Company Profiles

  • 10.1 AbbVie Inc. (Allergan Inc.)
    • 10.1.1. Company details
    • 10.1.2. Financial outlook
    • 10.1.3. Product summary
    • 10.1.4. Recent developments
  • 10.2 Apollo Hospitals Enterprise Limited
    • 10.2.1. Company details
    • 10.2.2. Financial outlook
    • 10.2.3. Product summary
    • 10.2.4. Recent developments
  • 10.3 Bausch Health Companies Inc.
    • 10.3.1. Company details
    • 10.3.2. Financial outlook
    • 10.3.3. Product summary
    • 10.3.4. Recent developments
  • 10.4 Cutera, Inc.
    • 10.4.1. Company details
    • 10.4.2. Financial outlook
    • 10.4.3. Product summary
    • 10.4.4. Recent developments
  • 10.5 Candela Medical
    • 10.5.1. Company details
    • 10.5.2. Financial outlook
    • 10.5.3. Product summary
    • 10.5.4. Recent developments
  • 10.6 Cynosure, Llc
    • 10.6.1. Company details
    • 10.6.2. Financial outlook
    • 10.6.3. Product summary
    • 10.6.4. Recent developments
  • 10.7 Lumenis Ltd
    • 10.7.1. Company details
    • 10.7.2. Financial outlook
    • 10.7.3. Product summary
    • 10.7.4. Recent developments
  • 10.8 Sciton Inc.
    • 10.8.1. Company details
    • 10.8.2. Financial outlook
    • 10.8.3. Product summary
    • 10.8.4. Recent developments
  • 10.9 Sisram Medical Ltd
    • 10.9.1. Company details
    • 10.9.2. Financial outlook
    • 10.9.3. Product summary
    • 10.9.4. Recent developments
  • 10.10. VLCC Health Care Limited
    • 10.10.1. Company details
    • 10.10.2. Financial outlook
    • 10.10.3. Product summary
    • 10.10.4. Recent developments